88 related articles for article (PubMed ID: 6108628)
1. [Adverse effects in the local treatment of glaucoma with beta-blockers].
Nielsen NV; Eriksen JS
Ugeskr Laeger; 1980 Sep; 142(36):2353-4. PubMed ID: 6108628
[No Abstract] [Full Text] [Related]
2. The safety of topical beta-blockers in glaucoma treatment.
Gale AE
Med J Aust; 1996 Aug; 165(3):175. PubMed ID: 8709892
[No Abstract] [Full Text] [Related]
3. [Adverse effects of local use of beta-blockaders in glaucoma. A literature review and a survey of reports to the adverse drug reaction authority 1986-95].
Nygaard HA; Høvding G
Tidsskr Nor Laegeforen; 1997 May; 117(14):2019-21. PubMed ID: 9235677
[TBL] [Abstract][Full Text] [Related]
4. New topical beta-blockers for glaucoma.
Drug Ther Bull; 1987 Aug; 25(16):63-4. PubMed ID: 2887414
[No Abstract] [Full Text] [Related]
5. Current use of ophthalmic beta blockers.
Gross RL; Pineyro A
J Glaucoma; 1997 Jun; 6(3):188-91. PubMed ID: 9211143
[No Abstract] [Full Text] [Related]
6. Resting pulse rates in a glaucoma clinic: the effect of topical and systemic beta-blocker usage.
Tattersall C; Vernon S; Singh R
Eye (Lond); 2006 Feb; 20(2):221-5. PubMed ID: 15803169
[TBL] [Abstract][Full Text] [Related]
7. [Beta-blockers in glaucoma].
Enache D
Oftalmologia; 1992; 36(2):101-9. PubMed ID: 1356020
[TBL] [Abstract][Full Text] [Related]
8. The safety of topical beta-blockers in glaucoma treatment.
Goldberg I
Med J Aust; 1996 Apr; 164(8):498-9. PubMed ID: 8614346
[TBL] [Abstract][Full Text] [Related]
9. Topical beta-blockers in patients with co-existing conditions: is this a cause for concern?
Good CB
Pharmacoepidemiol Drug Saf; 2001; 10(6):509-10. PubMed ID: 11828832
[No Abstract] [Full Text] [Related]
10. Cardiovascular and respiratory considerations with pharmacotherapy of glaucoma and ocular hypertension.
Han JA; Frishman WH; Wu Sun S; Palmiero PM; Petrillo R
Cardiol Rev; 2008; 16(2):95-108. PubMed ID: 18281912
[TBL] [Abstract][Full Text] [Related]
11. Depression and topical ophthalmic beta adrenergic blockade.
Bourgeois JA
J Am Optom Assoc; 1991 May; 62(5):403-6. PubMed ID: 1687576
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of the effectiveness of combined use of local and general hypotensive agents in patients with glaucoma and hypertension].
Zakharova IA; Makhmutov VIu; Pristavka VA; Kul'kova SV
Vestn Oftalmol; 2002; 118(1):44-6. PubMed ID: 11898362
[TBL] [Abstract][Full Text] [Related]
13. [Topical optical beta-adrenergic antagonists and quinidine--a risky combination].
Pianka P; Lazar M; Geyer O
Harefuah; 1998 Mar; 134(5):402-3. PubMed ID: 10909562
[No Abstract] [Full Text] [Related]
14. [The results of treating aphakic glaucoma with beta-blockers].
Kartasheva EA; Pimneva IV
Vestn Oftalmol; 1999; 115(5):32-3. PubMed ID: 10582020
[TBL] [Abstract][Full Text] [Related]
15. Practical tips on adverse drug effects in glaucoma therapy.
Schwab LT
W V Med J; 1983 Sep; 79(9):199-201. PubMed ID: 6138903
[No Abstract] [Full Text] [Related]
16. Beta blockers for glaucoma and excess risk of airways obstruction: population based cohort study.
Kirwan JF; Nightingale JA; Bunce C; Wormald R
BMJ; 2002 Dec; 325(7377):1396-7. PubMed ID: 12480856
[No Abstract] [Full Text] [Related]
17. [Efficacy of oral adrenergic beta blockers in the treatment of glaucoma].
Bonet S; Agustí A
Med Clin (Barc); 1998 Oct; 111(11):419. PubMed ID: 9834915
[No Abstract] [Full Text] [Related]
18. Topical beta-blockers and mortality.
Müskens RP; Wolfs RC; Witteman JC; Hofman A; de Jong PT; Stricker BH; Jansonius NM
Ophthalmology; 2008 Nov; 115(11):2037-43. PubMed ID: 18801580
[TBL] [Abstract][Full Text] [Related]
19. Topical beta-blockers are not associated with an increased risk of treatment for depression.
Kaiserman I; Kaiserman N; Elhayany A; Vinker S
Ophthalmology; 2006 Jul; 113(7):1077-80. PubMed ID: 16815397
[TBL] [Abstract][Full Text] [Related]
20. [Trusopt--a new form of drug for treating glaucoma].
Izdebska J
Klin Oczna; 1997; 99(3):217-20. PubMed ID: 9456571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
